Skip to main content
PACB logo

PACB · Pacific Biosciences Of California, Inc. · Debt

Track PACB — free
$1.86 -0.10 (-5.09%) Play latest call Q3 2026 earnings call transcript
Market Cap
$613.34M
Shares
312.93M
Volume · Nov 16 4.92M Avg daily vol (3M) 12.42M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-09-30 USD 2,067,000 10-Q filed 2026-11-05
Noncurrent convertible notes payable 2026-09-30 USD 643,058,000 10-Q filed 2026-11-05
Noncurrent operating lease liabilities 2026-09-30 USD 60,244,000 10-Q filed 2026-11-05
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1299130 CUSIP 69404D108 13F (30d) 158 filings 139 filers Visit website Investor relations